How is the Phathom Pharmaceuticals Inc today?

The Phathom Pharmaceuticals Inc today is trading in the down by -5.05% at 4.70.

What is Phathom Pharmaceuticals Inc Annual Revenue?

Phathom Pharmaceuticals Inc Annual Revenue rose 8,001.47%, in the last year to $55.25 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Phathom Pharmaceuticals Inc Annual Net Profit?

Phathom Pharmaceuticals Inc Annual Net Profit fell 65.84% in the last year to $334.33 M. Its sector's average net profit growth for the last fiscal year was -13.86%.

What is Phathom Pharmaceuticals Inc Price to Earning Ratio?

Phathom Pharmaceuticals Inc Price to Earning Ratio is -0.95, which is negative.

What is Phathom Pharmaceuticals Inc Stock Price?

Phathom Pharmaceuticals Inc Stock Price fell 54.5% and underperformed its sector by 82.94% in the past year.

What is Phathom Pharmaceuticals Inc Quarterly Revenue?

Phathom Pharmaceuticals Inc Quarterly Revenue rose 1,391.58% YoY to $28.52 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Phathom Pharmaceuticals Inc Quarterly Net profit?

Phathom Pharmaceuticals Inc Quarterly Net profit fell 13.84% YoY to $94.32 M. Its sector's average net profit growth YoY for the quarter was -238.4%.

What is Phathom Pharmaceuticals Inc Mutual Fund Holding?

Phathom Pharmaceuticals Inc Mutual Fund Holding decreased by 3.67% in the last quarter to 42.53.

What is Phathom Pharmaceuticals Inc Promoter Share Holding?

Phathom Pharmaceuticals Inc Promoter Share Holding increased by 0.06% in the most recent quarter to 3.04%.

What is Phathom Pharmaceuticals Inc Interest Coverage Ratio?

Phathom Pharmaceuticals Inc Interest Coverage Ratio is -3.64, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Phathom Pharmaceuticals Inc Institutional Holding?

Phathom Pharmaceuticals Inc Institutional Holding decreased by 4.05% in the last quarter to 80.62.

Phathom Pharmaceuticals Inc XNAS: PHAT

Phathom Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Phathom Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Phathom Pharmaceuticals Inc
Rating: 1.25983325
Author: Trendlyne DVM scores

about

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule...

4.70 -0.25 (-5.05%)

76.15% Fall from 52W High

823.9K XNAS Volume

XNAS 04 Jun, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

9.8 / 100

Technically Neutral

40.6 / 100

18

1Yr Price target upside is 275%

8 analysts

Phathom Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Phathom Pharmaceuticals Inc FAQ

How is Phathom Pharmaceuticals Inc today?

Phathom Pharmaceuticals Inc today is trading in the red, and is down by -5.05% at 4.70.

How has Phathom Pharmaceuticals Inc performed historically?

Phathom Pharmaceuticals Inc is currently trading down -5.05% on an intraday basis. In the past week the stock rose 14.08%. stock has been down -9.79% in the past quarter and fell -54.50% in the past year. You can view this in the overview section.